{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:34:56Z","timestamp":1789475696192,"version":"build-2803163510"},"reference-count":16,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.3892\/mco.2017.1261","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T07:45:44Z","timestamp":1494575144000},"page":"121-124","source":"Crossref","is-referenced-by-count":20,"title":["Modified glasgow prognostic score in patients with small-cell lung cancer"],"prefix":"10.3892","volume":"7","author":[{"given":"Koichi","family":"Kurishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Hizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"key20180107151441_b1-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/PL00012351","article-title":"Pancreatic cancer as a model: Inflammatory mediators, acute-phase response, and cancer cachexia","volume":"23","author":"Fearon","year":"1999","journal-title":"World J Surg"},{"key":"key20180107151441_b2-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/01635589809514687","article-title":"Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients","volume":"31","author":"McMillan","year":"1998","journal-title":"Nutr Cancer"},{"key":"key20180107151441_b3-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1207\/S15327914nc392_8","article-title":"Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss","volume":"39","author":"McMillan","year":"2001","journal-title":"Nutr Cancer"},{"key":"key20180107151441_b4-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clnu.2009.08.013","article-title":"The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer","volume":"29","author":"Meek","year":"2010","journal-title":"Clin Nutr"},{"key":"key20180107151441_b5-mco-0-0-1261","unstructured":"McMillanDCAn inflammation-based prognostic score and its role in the nutrition-based management of patients with cancerProc Nutr Soc67257262200810.1017\/S002966510800713118452641"},{"key":"key20180107151441_b6-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MCO.0b013e32832a7902","article-title":"Systemic inflammation, nutritional status and survival in patients with cancer","volume":"12","author":"McMillan","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"key20180107151441_b7-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MAJ.0b013e3181bccef5","article-title":"Small cell lung cancer: Are we making progress?","volume":"339","author":"Dowell","year":"2010","journal-title":"Am J Med Sci"},{"key":"key20180107151441_b8-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13277-014-2623-4","article-title":"A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer","volume":"36","author":"Zhou","year":"2015","journal-title":"Tumour Biol"},{"key":"key20180107151441_b9-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","article-title":"Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer","volume":"89","author":"Forrest","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180107151441_b10-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"key20180107151441_b11-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11605-010-1162-6","article-title":"Comparison of pre-treatment clinical prognostic factors in patients with gastro-oesophageal cancer and proposal of a new staging system","volume":"14","author":"Crumley","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"key20180107151441_b12-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1245\/s10434-010-1410-8","article-title":"Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer","volume":"18","author":"Roxburgh","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"key20180107151441_b13-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00432-015-2113-0","article-title":"Comparison of the glasgow prognostic score (GPS) and the modified glasgow prognostic score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer","volume":"142","author":"Fan","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107151441_b14-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s40064-016-2093-9","article-title":"Glasgow prognostic score predicts prognosis of non-small cell lung cancer: A meta-analysis","volume":"5","author":"Zhu","year":"2016","journal-title":"Springerplus"},{"key":"key20180107151441_b15-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): Results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"key20180107151441_b16-mco-0-0-1261","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s00520-016-3144-z","article-title":"Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: Results of a randomized phase 2 trial","volume":"24","author":"Takayama","year":"2016","journal-title":"Support Care Cancer"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T10:15:05Z","timestamp":1515320105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,12]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.3892\/mco.2017.1261"],"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1261","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]}}}